Morgan Stanley’s Qualigen Therapeutics QLGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,154
| Closed | -$34.3K | – | 8193 |
|
|
2024
Q4 | $34.3K | Buy |
+8,154
| New | +$34.3K | ﹤0.01% | 6402 |
|
|
2023
Q1 | – | Sell |
-8
| Closed | -$10 | – | 7806 |
|
|
2022
Q4 | $10 | Sell |
8
-3
| -27% | -$4 | ﹤0.01% | 7798 |
|
|
2022
Q3 | $0 | Buy |
11
+10
| +1,000% | – | ﹤0.01% | 7839 |
|
|
2022
Q2 | $0 | Sell |
1
-2,606
| -100% | – | ﹤0.01% | 7936 |
|
|
2022
Q1 | $2K | Buy |
2,607
+2,606
| +260,600% | +$2K | ﹤0.01% | 7754 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 8080 |
|
|
2021
Q2 | – | Sell |
-142
| Closed | – | – | 7788 |
|
|
2021
Q1 | $0 | Sell |
142
-2,303
| -94% | – | ﹤0.01% | 7543 |
|
|
2020
Q4 | $7K | Sell |
2,445
-495
| -17% | -$1.42K | ﹤0.01% | 6717 |
|
|
2020
Q3 | $14K | Sell |
2,940
-2,003
| -41% | -$9.54K | ﹤0.01% | 6171 |
|
|
2020
Q2 | $20K | Sell |
4,943
-7,057
| -59% | -$28.6K | ﹤0.01% | 6009 |
|
|
2020
Q1 | $3K | Buy |
+12,000
| New | +$3K | ﹤0.01% | 6335 |
|
|
2016
Q2 | – | Sell |
-14
| Closed | – | – | 6625 |
|
|
2016
Q1 | $0 | Buy |
14
+1
| +8% | – | ﹤0.01% | 6681 |
|
|
2015
Q4 | $0 | Buy |
+13
| New | – | ﹤0.01% | 6762 |
|